Read More

ARK’s Cathie Wood Dumps More Twitter Stock, Buys $20M in Fate Therapeutics Stock

Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds (ETF) valued at over $20 million based on Thursday’s closing pri

ARKK

Read More

Cathie Wood Adds $4.5M Worth Of Teladoc Shares, Cuts Stake Further In This Healthcare Stock

Cathie Wood-led Ark Investment Management bought 129,800 shares of healthcare company Teladoc Health Inc (NYSE: TDOC), valued at over $4.5 million, based on Tuesday’s closing price, via four of its exchange-traded funds (ETFs).

ARKK